Drug watch.
- Published in:
- 2007
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2007 AND VI 42 AND IP 4
Results: 25
1
2
Drug and formulary trends.
- Published in:
- 2007
- Publication type:
- Journal Article
3
The use of antibiotic pharmacodynamic end points in incremental cost-effectiveness analyses.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
4
Continuous erythropoiesis receptor activator (CERA)
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
5
56th Annual Scientific Session focuses on emerging clinical trial data, continuing research.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
6
Drug Watch.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 268
- Publication type:
- Article
7
No shortage of recommendations for PDUFA IV as Congress and professional organizations weigh in on drug safety.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 264
- By:
- Publication type:
- Article
8
Drug and Formulary Trends.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 263
- Publication type:
- Article
9
The use of antibiotic pharmacodynamic end points in incremental cost-effectiveness analyses.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 252
- By:
- Publication type:
- Article
10
E-prescribing offers a neat and safe alternative to pad and pen.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 250
- By:
- Publication type:
- Article
11
Imatinib demonstrates improved survival rates in patients with chronic myeloid leukemia.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 249
- Publication type:
- Article
12
Sunitinib demonstrates superior survival, quality-of-life benefits compared with interferon alfa.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 245
- Publication type:
- Article
13
Salmeterol plus fluticasone fails to reduce mortality in patients with COPD.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 245
- Publication type:
- Article
14
Continuous erythropoiesis receptor activator (CERA).
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 233
- By:
- Publication type:
- Article
15
56th Annual Scientific Session focuses on emerging clinical trial data, continuing research.
- Published in:
- 2007
- By:
- Publication type:
- Proceeding
16
Med Safety actions in brief.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 220
- Publication type:
- Article
17
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 218
- Publication type:
- Article
18
Rate of anticoagulant-associated intracerebral hemorrhage quintuples.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 218
- Publication type:
- Article
19
FDA actions in brief.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 217
- Publication type:
- Article
20
First-time generic approvals.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 216
- Publication type:
- Article
21
New indication: Humira.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 216
- Publication type:
- Article
22
New biologic: Soliris.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 215
- Publication type:
- Article
23
Pipeline preview.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 214
- Publication type:
- Article
24
New molecular entities: Tykerb.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 214
- Publication type:
- Article
25
New molecular entities: Tekturna.
- Published in:
- Formulary, 2007, v. 42, n. 4, p. 214
- Publication type:
- Article